Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels
Authors
Keywords
-
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 385, Issue 10, Pages 1003-1016
Publisher
Springer Nature
Online
2013-02-16
DOI
10.1007/s00210-012-0780-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crystal Structure of the Human K2P TRAAK, a Lipid- and Mechano-Sensitive K+ Ion Channel
- (2012) S. G. Brohawn et al. SCIENCE
- Crystal Structure of the Human Two-Pore Domain Potassium Channel K2P1
- (2012) A. N. Miller et al. SCIENCE
- The hERG K+ channel S4 domain L532P mutation: Characterization at 37°C
- (2011) Yi H. Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Identification and functional characterization of zebrafish K2P10.1 (TREK2) two-pore-domain K+ channels
- (2011) Jakob Gierten et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Carvedilol targets human K2P3.1 (TASK1) K+leak channels
- (2011) K Staudacher et al. BRITISH JOURNAL OF PHARMACOLOGY
- PKC-dependent activation of human K2P18.1 K+ channels
- (2011) Ann-Kathrin Rahm et al. BRITISH JOURNAL OF PHARMACOLOGY
- TASK1 (K2P3.1) K+ channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation
- (2011) C Seyler et al. BRITISH JOURNAL OF PHARMACOLOGY
- TASK-1 Channels May Modulate Action Potential Duration of Human Atrial Cardiomyocytes
- (2011) Sven H. Limberg et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Knock-Out of the Potassium Channel TASK-1 Leads to a Prolonged QT Interval and a Disturbed QRS Complex
- (2011) Niels Decher et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Atrial Fibrillation Pathophysiology
- (2011) Yu-ki Iwasaki et al. CIRCULATION
- A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore
- (2011) Anne K. Streit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alternative splicing determines mRNA translation initiation and function of human K2P10.1 K+channels
- (2011) Kathrin Staudacher et al. JOURNAL OF PHYSIOLOGY-LONDON
- Effect of dronedarone on Na+, Ca2+ and HCN channels
- (2011) Roman Bogdan et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Dronedarone in High-Risk Permanent Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability
- (2010) Birgit C. Donner et al. BASIC RESEARCH IN CARDIOLOGY
- TREK-1 K+ Channels in the Cardiovascular System: Their Significance and Potential as a Therapeutic Target
- (2010) Lakshman Goonetilleke et al. Cardiovascular Therapeutics
- Structural models of TREK channels and their gating mechanism
- (2010) Adina Milac et al. Channels
- Clinical Pharmacology of Dronedarone: Implications for the Therapy of Atrial Fibrillation
- (2010) Paul Dorian JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- New antiarrhythmic drugs for treatment of atrial fibrillation
- (2010) Dobromir Dobrev et al. LANCET
- Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine
- (2010) Sabrina Obers et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Novel pharmacological approaches for antiarrhythmic therapy
- (2010) Ursula Ravens NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine
- (2010) Ingo Staudacher et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Novel Approaches for Pharmacological Management of Atrial Fibrillation
- (2009) Joachim R. Ehrlich et al. DRUGS
- Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation
- (2009) Niels Voigt et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone
- (2009) Jakob Gierten et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
- (2009) Stefan H. Hohnloser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein
- (2008) J Gierten et al. BRITISH JOURNAL OF PHARMACOLOGY
- Two-pore potassium channels in the cardiovascular system
- (2008) Alison Gurney et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Atrial-Selective Approaches for the Treatment of Atrial Fibrillation
- (2008) Joachim R. Ehrlich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes
- (2008) Yasuhide Watanabe et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Alternative Translation Initiation in Rat Brain Yields K2P2.1 Potassium Channels Permeable to Sodium
- (2008) Dierk Thomas et al. NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now